590 related articles for article (PubMed ID: 23816796)
21. Evidences for the agmatine involvement in antidepressant like effect of bupropion in mouse forced swim test.
Kotagale NR; Tripathi SJ; Aglawe MM; Chopde CT; Umekar MJ; Taksande BG
Pharmacol Biochem Behav; 2013 Jun; 107():42-7. PubMed ID: 23583442
[TBL] [Abstract][Full Text] [Related]
22. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation.
Sørensen G; Lindberg C; Wörtwein G; Bolwig TG; Woldbye DP
J Neurosci Res; 2004 Sep; 77(5):723-9. PubMed ID: 15352219
[TBL] [Abstract][Full Text] [Related]
23. [5-HT1A/1B receptors, alpha2-adrenoceptors and the post-receptor adenylate cyclase activation in the mice brain are involved in the antidepressant-like action of agmatine].
Jiang XZ; Li YF; Zhang YZ; Chen HX; Li J; Wang NP
Yao Xue Xue Bao; 2008 May; 43(5):467-73. PubMed ID: 18717332
[TBL] [Abstract][Full Text] [Related]
24. [Antidepressant effect of microinjection of neuropeptide Y into the hippocampus is mediated by decreased expression of nitric oxide synthase].
Lian T; An SC
Sheng Li Xue Bao; 2010 Jun; 62(3):237-46. PubMed ID: 20571741
[TBL] [Abstract][Full Text] [Related]
25. Levetiracetam prevents changes in levels of brain-derived neurotrophic factor and neuropeptide Y mRNA and of Y1- and Y5-like receptors in the hippocampus of rats undergoing amygdala kindling: implications for antiepileptogenic and mood-stabilizing properties.
Husum H; Bolwig TG; Sánchez C; Mathé AA; Hansen SL
Epilepsy Behav; 2004 Apr; 5(2):204-15. PubMed ID: 15123022
[TBL] [Abstract][Full Text] [Related]
26. Involvement of neuropeptide Y Y1 receptors in the regulation of neuroendocrine corticotropin-releasing hormone neuronal activity.
Dimitrov EL; DeJoseph MR; Brownfield MS; Urban JH
Endocrinology; 2007 Aug; 148(8):3666-73. PubMed ID: 17463058
[TBL] [Abstract][Full Text] [Related]
27. Evidence for the involvement of the opioid system in the agmatine antidepressant-like effect in the forced swimming test.
Zomkowski AD; Santos AR; Rodrigues AL
Neurosci Lett; 2005 Jun; 381(3):279-83. PubMed ID: 15896484
[TBL] [Abstract][Full Text] [Related]
28. Neuropeptide Y (NPY) prevents depressive-like behavior, spatial memory deficits and oxidative stress following amyloid-β (Aβ(1-40)) administration in mice.
dos Santos VV; Santos DB; Lach G; Rodrigues AL; Farina M; De Lima TC; Prediger RD
Behav Brain Res; 2013 May; 244():107-15. PubMed ID: 23396168
[TBL] [Abstract][Full Text] [Related]
29. Involvement of neuropeptide Y Y(1) receptors in the acute, chronic and withdrawal effects of nicotine on feeding and body weight in rats.
Nakhate KT; Dandekar MP; Kokare DM; Subhedar NK
Eur J Pharmacol; 2009 May; 609(1-3):78-87. PubMed ID: 19285064
[TBL] [Abstract][Full Text] [Related]
30. Involvement of neuropeptide Y Y1 receptors in the regulation of LH and GH cells in the pituitary of the catfish, Clarias batrachus: an immunocytochemical study.
Mazumdar M; Lal B; Sakharkar AJ; Deshmukh M; Singru PS; Subhedar N
Gen Comp Endocrinol; 2006 Nov; 149(2):190-6. PubMed ID: 16828090
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226.
Doods HN; Wienen W; Entzeroth M; Rudolf K; Eberlein W; Engel W; Wieland HA
J Pharmacol Exp Ther; 1995 Oct; 275(1):136-42. PubMed ID: 7562541
[TBL] [Abstract][Full Text] [Related]
32. Infusions of neuropeptide Y into the lateral septum reduce anxiety-related behaviors in the rat.
Trent NL; Menard JL
Pharmacol Biochem Behav; 2011 Oct; 99(4):580-90. PubMed ID: 21693128
[TBL] [Abstract][Full Text] [Related]
33. Neuropeptide Y-Y1 receptor modulates nitric oxide level during stroke in the rat.
Chen SH; Fung PC; Cheung RT
Free Radic Biol Med; 2002 Apr; 32(8):776-84. PubMed ID: 11937303
[TBL] [Abstract][Full Text] [Related]
34. Central NPY receptor-mediated alteration of heart rate dynamics in mice during expression of fear conditioned to an auditory cue.
Tovote P; Meyer M; Beck-Sickinger AG; von Hörsten S; Ove Ogren S; Spiess J; Stiedl O
Regul Pept; 2004 Aug; 120(1-3):205-14. PubMed ID: 15177939
[TBL] [Abstract][Full Text] [Related]
35. Vascular neuropeptide Y Y1-receptors in the rat kidney: vasoconstrictor effects and expression of Y1-receptor mRNA.
Modin A; Malmström RE; Meister B
Neuropeptides; 1999 Aug; 33(4):253-9. PubMed ID: 10657500
[TBL] [Abstract][Full Text] [Related]
36. Neuropeptide Y inhibits capsaicin-sensitive nociceptors via a Y1-receptor-mediated mechanism.
Gibbs J; Flores CM; Hargreaves KM
Neuroscience; 2004; 125(3):703-9. PubMed ID: 15099684
[TBL] [Abstract][Full Text] [Related]
37. Tolerance to ethanol sedation and withdrawal hyper-excitability is mediated via neuropeptide Y Y1 and Y5 receptors.
Bhisikar SM; Kokare DM; Nakhate KT; Chopde CT; Subhedar NK
Life Sci; 2009 Nov; 85(21-22):765-72. PubMed ID: 19846044
[TBL] [Abstract][Full Text] [Related]
38. Receptor subtypes Y1 and Y5 mediate neuropeptide Y induced feeding in the guinea-pig.
Lecklin A; Lundell I; Paananen L; Wikberg JE; Männistö PT; Larhammar D
Br J Pharmacol; 2002 Apr; 135(8):2029-37. PubMed ID: 11959807
[TBL] [Abstract][Full Text] [Related]
39. Involvement of Y(5) receptors in neuropeptide Y agonist-induced analgesic-like effect in the rat hot plate test.
Thomsen M; Wörtwein G; Olesen MV; Begtrup M; Havez S; Bolwig TG; Woldbye DP
Brain Res; 2007 Jun; 1155():49-55. PubMed ID: 17498669
[TBL] [Abstract][Full Text] [Related]
40. The neuropeptide Y Y1 receptor subtype is necessary for the anxiolytic-like effects of neuropeptide Y, but not the antidepressant-like effects of fluoxetine, in mice.
Karlsson RM; Choe JS; Cameron HA; Thorsell A; Crawley JN; Holmes A; Heilig M
Psychopharmacology (Berl); 2008 Jan; 195(4):547-57. PubMed ID: 17891380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
